{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T20:29:17Z","timestamp":1781036957171,"version":"3.54.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["NRRPG3P0011"],"award-info":[{"award-number":["NRRPG3P0011"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CORPG3L0301"],"award-info":[{"award-number":["CORPG3L0301"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2311-B-182A-001"],"award-info":[{"award-number":["113-2311-B-182A-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03849-0","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T12:09:20Z","timestamp":1750507760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Perspectives on NcRNAs in HBV\/cccDNA-driven HCC progression"],"prefix":"10.1186","volume":"25","author":[{"given":"Yang-Hsiang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Wei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau-Ting","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wey-Ran","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"issue":"1","key":"3849_CR1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.17998\/jlc.2024.03.13","volume":"24","author":"DY Kim","year":"2024","unstructured":"Kim DY. Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide. J Liver Cancer. 2024;24(1):62\u201370.","journal-title":"J Liver Cancer"},{"issue":"6","key":"3849_CR2","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598\u2013606.","journal-title":"J Hepatol"},{"key":"3849_CR3","doi-asserted-by":"publisher","first-page":"101730","DOI":"10.1016\/j.tranon.2023.101730","volume":"35","author":"KR Uppaluri","year":"2023","unstructured":"Uppaluri KR, Challa HJ, Gaur A, Jain R, Krishna Vardhani K, Geddam A, et al. Unlocking the potential of non-coding RNAs in cancer research and therapy. Transl Oncol. 2023;35:101730.","journal-title":"Transl Oncol"},{"issue":"6","key":"3849_CR4","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jhep.2024.06.037","volume":"81","author":"F Zoulim","year":"2024","unstructured":"Zoulim F, Chen PJ, Dandri M, Kennedy PT, Seeger C. Hepatitis B virus DNA integration: implications for diagnostics, therapy, and outcome. J Hepatol. 2024;81(6):1087\u201399.","journal-title":"J Hepatol"},{"key":"3849_CR5","doi-asserted-by":"crossref","unstructured":"di Filippo Villa D, Navas MC. Vertical transmission of hepatitis B Virus-An update. Microorganisms. 2023;11(5).","DOI":"10.3390\/microorganisms11051140"},{"issue":"4","key":"3849_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5223\/pghn.2020.23.4.311","volume":"23","author":"FT Lu","year":"2020","unstructured":"Lu FT, Ni YH. Elimination of Mother-to-Infant transmission of hepatitis B virus: 35 years of experience. Pediatr Gastroenterol Hepatol Nutr. 2020;23(4):311\u20138.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"3849_CR7","doi-asserted-by":"publisher","first-page":"204020662092133","DOI":"10.1177\/2040206620921331","volume":"28","author":"MA Abd El Aziz","year":"2020","unstructured":"Abd El Aziz MA, Sacco R, Facciorusso A. Nucleos(t)ide analogues and hepatitis B virus-related hepatocellular carcinoma: A literature review. Antivir Chem Chemother. 2020;28:2040206620921331.","journal-title":"Antivir Chem Chemother"},{"issue":"23","key":"3849_CR8","doi-asserted-by":"publisher","first-page":"6451","DOI":"10.1016\/j.cell.2024.10.024","volume":"187","author":"LL Chen","year":"2024","unstructured":"Chen LL, Kim VN. Small and long non-coding rnas: past, present, and future. Cell. 2024;187(23):6451\u201385.","journal-title":"Cell"},{"issue":"15","key":"3849_CR9","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.7150\/ijbs.99683","volume":"20","author":"YH Lin","year":"2024","unstructured":"Lin YH, Chi HC, Wu MH, Liao CJ, Chen CY, Huang PS, et al. The novel role of LOC344887 in the enhancement of hepatocellular carcinoma progression via modulation of SHP1-regulated STAT3\/HMGA2 signaling axis. Int J Biol Sci. 2024;20(15):6281\u201396.","journal-title":"Int J Biol Sci"},{"key":"3849_CR10","doi-asserted-by":"publisher","first-page":"1374636","DOI":"10.3389\/fgene.2024.1374636","volume":"15","author":"M Gama-Carvalho","year":"2024","unstructured":"Gama-Carvalho M, Tran N, Editorial. Non-coding RNA elements as regulators of host-pathogen interactions. Front Genet. 2024;15:1374636.","journal-title":"Front Genet"},{"key":"3849_CR11","doi-asserted-by":"publisher","first-page":"155170","DOI":"10.1016\/j.prp.2024.155170","volume":"255","author":"KS Alharbi","year":"2024","unstructured":"Alharbi KS. Noncoding RNAs in hepatitis: unraveling the apoptotic pathways. Pathol Res Pract. 2024;255:155170.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"3849_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12935-023-03186-0","volume":"24","author":"S Li","year":"2024","unstructured":"Li S, Peng M, Tan S, Oyang L, Lin J, Xia L, et al. The roles and molecular mechanisms of non-coding RNA in cancer metabolic reprogramming. Cancer Cell Int. 2024;24(1):37.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"3849_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s40364-024-00611-y","volume":"12","author":"M Zhang","year":"2024","unstructured":"Zhang M, Chen H, Liu H, Tang H. The impact of integrated hepatitis B virus DNA on oncogenesis and antiviral therapy. Biomark Res. 2024;12(1):84.","journal-title":"Biomark Res"},{"key":"3849_CR14","doi-asserted-by":"publisher","first-page":"1322892","DOI":"10.3389\/fmicb.2023.1322892","volume":"14","author":"F Wang","year":"2023","unstructured":"Wang F, Song H, Xu F, Xu J, Wang L, Yang F, et al. Role of hepatitis B virus non-structural protein HBx on HBV replication, interferon signaling, and hepatocarcinogenesis. Front Microbiol. 2023;14:1322892.","journal-title":"Front Microbiol"},{"issue":"2","key":"3849_CR15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.gendis.2023.02.050","volume":"11","author":"A Gajos-Michniewicz","year":"2024","unstructured":"Gajos-Michniewicz A, Czyz M. WNT\/beta-catenin signaling in hepatocellular carcinoma: the aberrant activation, pathogenic roles, and therapeutic opportunities. Genes Dis. 2024;11(2):727\u201346.","journal-title":"Genes Dis"},{"key":"3849_CR16","doi-asserted-by":"publisher","first-page":"106553","DOI":"10.1016\/j.phrs.2022.106553","volume":"187","author":"MDA Paskeh","year":"2023","unstructured":"Paskeh MDA, Ghadyani F, Hashemi M, Abbaspour A, Zabolian A, Javanshir S, et al. Biological impact and therapeutic perspective of targeting PI3K\/Akt signaling in hepatocellular carcinoma: promises and challenges. Pharmacol Res. 2023;187:106553.","journal-title":"Pharmacol Res"},{"issue":"1","key":"3849_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41698-024-00697-5","volume":"8","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhang J, Zhai Z, Liu C, Yang S, Zhou Y, et al. Upregulated PrP(C) by HBx enhances NF-kappaB signal via liquid-liquid phase separation to advance liver cancer. NPJ Precis Oncol. 2024;8(1):211.","journal-title":"NPJ Precis Oncol"},{"issue":"6","key":"3849_CR18","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/s41388-020-01593-5","volume":"40","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Yan Q, Gong L, Xu H, Liu B, Fang X, et al. C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism. Oncogene. 2021;40(6):1147\u201361.","journal-title":"Oncogene"},{"issue":"28","key":"3849_CR19","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1038\/s41388-021-01905-3","volume":"40","author":"YH Lin","year":"2021","unstructured":"Lin YH, Wu MH, Liu YC, Lyu PC, Yeh CT, Lin KH. LINC01348 suppresses hepatocellular carcinoma metastasis through Inhibition of SF3B3-mediated EZH2 pre-mRNA splicing. Oncogene. 2021;40(28):4675\u201385.","journal-title":"Oncogene"},{"issue":"5","key":"3849_CR20","doi-asserted-by":"publisher","first-page":"866","DOI":"10.4254\/wjh.v14.i5.866","volume":"14","author":"C Bianca","year":"2022","unstructured":"Bianca C, Sidhartha E, Tiribelli C, El-Khobar KE, Sukowati CHC. Role of hepatitis B virus in development of hepatocellular carcinoma: focus on covalently closed circular DNA. World J Hepatol. 2022;14(5):866\u201384.","journal-title":"World J Hepatol"},{"key":"3849_CR21","doi-asserted-by":"publisher","first-page":"104824","DOI":"10.1016\/j.antiviral.2020.104824","volume":"180","author":"Y Xia","year":"2020","unstructured":"Xia Y, Guo H. Hepatitis B virus cccdna: formation, regulation and therapeutic potential. Antiviral Res. 2020;180:104824.","journal-title":"Antiviral Res"},{"issue":"1","key":"3849_CR22","doi-asserted-by":"publisher","first-page":"101215","DOI":"10.1016\/j.gendis.2024.101215","volume":"12","author":"J Ren","year":"2025","unstructured":"Ren J, Cheng S, Ren F, Gu H, Wu D, Yao X, et al. Epigenetic regulation and its therapeutic potential in hepatitis B virus covalently closed circular DNA. Genes Dis. 2025;12(1):101215.","journal-title":"Genes Dis"},{"key":"3849_CR23","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.3389\/fimmu.2018.03138","volume":"9","author":"P Wang","year":"2018","unstructured":"Wang P. The opening of pandora\u2019s box: an emerging role of long noncoding RNA in viral infections. Front Immunol. 2018;9:3138.","journal-title":"Front Immunol"},{"issue":"2","key":"3849_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4161\/rna.18827","volume":"9","author":"C Jopling","year":"2012","unstructured":"Jopling C. Liver-specific microRNA-122: biogenesis and function. RNA Biol. 2012;9(2):137\u201342.","journal-title":"RNA Biol"},{"issue":"3","key":"3849_CR25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/hep.24809","volume":"55","author":"S Wang","year":"2012","unstructured":"Wang S, Qiu L, Yan X, Jin W, Wang Y, Chen L, et al. Loss of MicroRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through Cyclin G(1) -modulated P53 activity. Hepatology. 2012;55(3):730\u201341.","journal-title":"Hepatology"},{"issue":"12","key":"3849_CR26","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1096\/fj.11-187781","volume":"25","author":"Y Chen","year":"2011","unstructured":"Chen Y, Shen A, Rider PJ, Yu Y, Wu K, Mu Y, et al. A liver-specific MicroRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEB J. 2011;25(12):4511\u201321.","journal-title":"FASEB J"},{"key":"3849_CR27","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.2147\/DMSO.S373385","volume":"15","author":"H Yang","year":"2022","unstructured":"Yang H, Rui F, Li R, Yin S, Xue Q, Hu X, et al. ADAR1 inhibits HBV DNA replication via regulating miR-122-5p in palmitic acid treated HepG2.2.15 cells. Diabetes Metab Syndr Obes. 2022;15:4035\u201347.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"3849_CR28","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1002\/hep.26514","volume":"58","author":"K Song","year":"2013","unstructured":"Song K, Han C, Zhang J, Lu D, Dash S, Feitelson M, et al. Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells. Hepatology. 2013;58(5):1681\u201392.","journal-title":"Hepatology"},{"issue":"4","key":"3849_CR29","first-page":"926","volume":"79","author":"AD Ladd","year":"2024","unstructured":"Ladd AD, Duarte S, Sahin I, Zarrinpar A. Mechanisms of drug resistance in HCC. Hepatology. 2024;79(4):926\u201340.","journal-title":"Hepatology"},{"issue":"14","key":"3849_CR30","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1158\/0008-5472.CAN-08-4797","volume":"69","author":"F Fornari","year":"2009","unstructured":"Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, et al. MiR-122\/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2009;69(14):5761\u20137.","journal-title":"Cancer Res"},{"key":"3849_CR31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.yexmp.2018.10.009","volume":"106","author":"F Cao","year":"2019","unstructured":"Cao F, Yin LX. miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt\/beta-catenin pathway. Exp Mol Pathol. 2019;106:34\u201343.","journal-title":"Exp Mol Pathol"},{"issue":"6","key":"3849_CR32","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.aohep.2019.07.005","volume":"18","author":"X Wei","year":"2019","unstructured":"Wei X, Liu H, Li X, Liu X. Over-expression of MiR-122 promotes apoptosis of hepatocellular carcinoma via targeting TLR4. Ann Hepatol. 2019;18(6):869\u201378.","journal-title":"Ann Hepatol"},{"issue":"12","key":"3849_CR33","doi-asserted-by":"publisher","first-page":"5157","DOI":"10.1093\/nar\/gkr067","volume":"39","author":"N Potenza","year":"2011","unstructured":"Potenza N, Papa U, Mosca N, Zerbini F, Nobile V, Russo A. Human MicroRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res. 2011;39(12):5157\u201363.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3849_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbrc.2014.05.009","volume":"449","author":"N Mosca","year":"2014","unstructured":"Mosca N, Castiello F, Coppola N, Trotta MC, Sagnelli C, Pisaturo M, et al. Functional interplay between hepatitis B virus X protein and human miR-125a in HBV infection. Biochem Biophys Res Commun. 2014;449(1):141\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"3849_CR35","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3727\/096504017X15016337254623","volume":"27","author":"G Li","year":"2019","unstructured":"Li G, Zhang W, Gong L, Huang X. MicroRNA 125a-5p inhibits cell proliferation and induces apoptosis in hepatitis B Virus-Related hepatocellular carcinoma by downregulation of ErbB3. Oncol Res. 2019;27(4):449\u201358.","journal-title":"Oncol Res"},{"key":"3849_CR36","doi-asserted-by":"crossref","unstructured":"Liu N, Yang C, Gao A, Sun M, Lv D. MiR-101: an important regulator of gene expression and tumor ecosystem. Cancers (Basel). 2022;14(23).","DOI":"10.3390\/cancers14235861"},{"issue":"1","key":"3849_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.bbrc.2017.03.171","volume":"487","author":"Y Wang","year":"2017","unstructured":"Wang Y, Tian H. miR-101 suppresses HBV replication and expression by targeting FOXO1 in hepatoma carcinoma cell lines. Biochem Biophys Res Commun. 2017;487(1):167\u201372.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"3849_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1139\/bcb-2013-0128","volume":"92","author":"Y Sheng","year":"2014","unstructured":"Sheng Y, Ding S, Chen K, Chen J, Wang S, Zou C, et al. Functional analysis of miR-101-3p and Rap1b involved in hepatitis B virus-related hepatocellular carcinoma pathogenesis. Biochem Cell Biol. 2014;92(2):152\u201362.","journal-title":"Biochem Cell Biol"},{"issue":"9","key":"3849_CR39","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1007\/s00705-014-2084-5","volume":"159","author":"Y Sheng","year":"2014","unstructured":"Sheng Y, Li J, Zou C, Wang S, Cao Y, Zhang J, et al. Downregulation of miR-101-3p by hepatitis B virus promotes proliferation and migration of hepatocellular carcinoma cells by targeting Rab5a. Arch Virol. 2014;159(9):2397\u2013410.","journal-title":"Arch Virol"},{"issue":"6","key":"3849_CR40","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.3892\/ol.2013.1638","volume":"6","author":"Y Fu","year":"2013","unstructured":"Fu Y, Wei X, Tang C, Li J, Liu R, Shen A, et al. Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma. Oncol Lett. 2013;6(6):1811\u20135.","journal-title":"Oncol Lett"},{"key":"3849_CR41","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3389\/fonc.2020.01271","volume":"10","author":"J Xu","year":"2020","unstructured":"Xu J, An P, Winkler CA, Yu Y. Dysregulated MicroRNAs in hepatitis B Virus-Related hepatocellular carcinoma: potential as biomarkers and therapeutic targets. Front Oncol. 2020;10:1271.","journal-title":"Front Oncol"},{"issue":"1","key":"3849_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13008-023-00106-6","volume":"19","author":"H Gao","year":"2024","unstructured":"Gao H, Gao Z, Liu X, Sun X, Hu Z, Song Z, et al. miR-101-3p-mediated role of PDZK1 in hepatocellular carcinoma progression and the underlying PI3K\/Akt signaling mechanism. Cell Div. 2024;19(1):9.","journal-title":"Cell Div"},{"issue":"1","key":"3849_CR43","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41420-024-02193-y","volume":"10","author":"X Mu","year":"2024","unstructured":"Mu X, Wei Y, Fan X, Zhang R, Xi W, Zheng G, et al. Aberrant activation of a miR-101-UBE2D1 axis contributes to the advanced progression and chemotherapy sensitivity in human hepatocellular carcinoma. Cell Death Discov. 2024;10(1):422.","journal-title":"Cell Death Discov"},{"issue":"1","key":"3849_CR44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s10238-025-01622-1","volume":"25","author":"W Zhu","year":"2025","unstructured":"Zhu W, Ni Q, Wang Z, Zhang R, Liu F, Chang H. MiR-101-3p targets the PI3K-AKT signaling pathway via Birc5 to inhibit invasion, proliferation, and epithelial-mesenchymal transition in hepatocellular carcinoma. Clin Exp Med. 2025;25(1):88.","journal-title":"Clin Exp Med"},{"key":"3849_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.omtn.2022.05.031","volume":"29","author":"Y Liu","year":"2022","unstructured":"Liu Y, Wang J, Chen J, Wu S, Zeng X, Xiong Q, et al. Upregulation of miR-520c-3p via hepatitis B virus drives hepatocellular migration and invasion by the PTEN\/AKT\/NF-kappaB axis. Mol Ther Nucleic Acids. 2022;29:47\u201363.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"3849_CR46","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/hepr.12121","volume":"44","author":"HL Miao","year":"2014","unstructured":"Miao HL, Lei CJ, Qiu ZD, Liu ZK, Li R, Bao ST, et al. MicroRNA-520c-3p inhibits hepatocellular carcinoma cell proliferation and invasion through induction of cell apoptosis by targeting glypican-3. Hepatol Res. 2014;44(3):338\u201348.","journal-title":"Hepatol Res"},{"issue":"2","key":"3849_CR47","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2174\/1871520620666200502004817","volume":"21","author":"MA Ragheb","year":"2021","unstructured":"Ragheb MA, Soliman MH, Elzayat EM, Mohamed MS, El-Ekiaby N, Abdelaziz AI, et al. MicroRNA-520c-3p modulates Doxorubicin-Chemosensitivity in HepG2 cells. Anticancer Agents Med Chem. 2021;21(2):237\u201345.","journal-title":"Anticancer Agents Med Chem"},{"issue":"3","key":"3849_CR48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ccr.2014.01.030","volume":"25","author":"CC Lau","year":"2014","unstructured":"Lau CC, Sun T, Ching AK, He M, Li JW, Wong AM, et al. Viral-human chimeric transcript predisposes risk to liver cancer development and progression. Cancer Cell. 2014;25(3):335\u201349.","journal-title":"Cancer Cell"},{"issue":"2","key":"3849_CR49","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jhep.2015.09.013","volume":"64","author":"HW Liang","year":"2016","unstructured":"Liang HW, Wang N, Wang Y, Wang F, Fu Z, Yan X, et al. Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122. J Hepatol. 2016;64(2):278\u201391.","journal-title":"J Hepatol"},{"key":"3849_CR50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.canlet.2019.04.008","volume":"454","author":"Y Liu","year":"2019","unstructured":"Liu Y, Feng J, Sun M, Yang G, Yuan H, Wang Y, et al. Long non-coding RNA HULC activates HBV by modulating HBx\/STAT3\/miR-539\/APOBEC3B signaling in HBV-related hepatocellular carcinoma. Cancer Lett. 2019;454:158\u201370.","journal-title":"Cancer Lett"},{"key":"3849_CR51","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.antiviral.2017.11.006","volume":"149","author":"Y Chen","year":"2018","unstructured":"Chen Y, Hu J, Cai X, Huang Y, Zhou X, Tu Z, et al. APOBEC3B edits HBV DNA and inhibits HBV replication during reverse transcription. Antiviral Res. 2018;149:16\u201325.","journal-title":"Antiviral Res"},{"issue":"2","key":"3849_CR52","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.intimp.2015.04.028","volume":"28","author":"J Zhao","year":"2015","unstructured":"Zhao J, Fan Y, Wang K, Ni X, Gu J, Lu H, et al. LncRNA HULC affects the differentiation of Treg in HBV-related liver cirrhosis. Int Immunopharmacol. 2015;28(2):901\u20135.","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"3849_CR53","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1002\/jcb.26555","volume":"119","author":"Z Jiang","year":"2018","unstructured":"Jiang Z, Liu H. Metformin inhibits tumorigenesis in HBV-induced hepatocellular carcinoma by suppressing HULC overexpression caused by HBX. J Cell Biochem. 2018;119(6):4482\u201395.","journal-title":"J Cell Biochem"},{"issue":"24","key":"3849_CR54","doi-asserted-by":"publisher","first-page":"7345","DOI":"10.7150\/thno.37173","volume":"9","author":"G Yang","year":"2019","unstructured":"Yang G, Feng J, Liu Y, Zhao M, Yuan Y, Yuan H, et al. HAT1 signaling confers to assembly and epigenetic regulation of HBV CccDNA minichromosome. Theranostics. 2019;9(24):7345\u201358.","journal-title":"Theranostics"},{"issue":"20","key":"3849_CR55","doi-asserted-by":"publisher","first-page":"9111","DOI":"10.18632\/aging.102378","volume":"11","author":"H Zhang","year":"2019","unstructured":"Zhang H, Liao Z, Liu F, Su C, Zhu H, Li Y, et al. Long noncoding RNA HULC promotes hepatocellular carcinoma progression. Aging. 2019;11(20):9111\u201327.","journal-title":"Aging"},{"issue":"4","key":"3849_CR56","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1002\/cam4.5263","volume":"12","author":"S Liu","year":"2023","unstructured":"Liu S, Huttad L, He G, He W, Liu C, Cai D, et al. Long noncoding RNA HULC regulates the NF-kappaB pathway and represents a promising prognostic biomarker in liver cancer. Cancer Med. 2023;12(4):5124\u201336.","journal-title":"Cancer Med"},{"issue":"11","key":"3849_CR57","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1136\/gutjnl-2019-319637","volume":"69","author":"D Salerno","year":"2020","unstructured":"Salerno D, Chiodo L, Alfano V, Floriot O, Cottone G, Paturel A, et al. Hepatitis B protein HBx binds the DLEU2 LncRNA to sustain CccDNA and host cancer-related gene transcription. Gut. 2020;69(11):2016\u201324.","journal-title":"Gut"},{"key":"3849_CR58","doi-asserted-by":"publisher","first-page":"109272","DOI":"10.1016\/j.biopha.2019.109272","volume":"118","author":"Y Guo","year":"2019","unstructured":"Guo Y, Bai M, Lin L, Huang J, An Y, Liang L, et al. LncRNA DLEU2 aggravates the progression of hepatocellular carcinoma through binding to EZH2. Biomed Pharmacother. 2019;118:109272.","journal-title":"Biomed Pharmacother"},{"key":"3849_CR59","doi-asserted-by":"crossref","unstructured":"Lin YH, Yeh CT, Chen CY, Lin KH. Pseudogene: relevant or irrelevant?? Biomed J. 2024:100790.","DOI":"10.1016\/j.bj.2024.100790"},{"issue":"18","key":"3849_CR60","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.7150\/thno.34273","volume":"9","author":"J Feng","year":"2019","unstructured":"Feng J, Yang G, Liu Y, Gao Y, Zhao M, Bu Y, et al. LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer. Theranostics. 2019;9(18):5227\u201345.","journal-title":"Theranostics"},{"key":"3849_CR61","doi-asserted-by":"publisher","first-page":"6627173","DOI":"10.1155\/2021\/6627173","volume":"2021","author":"M He","year":"2021","unstructured":"He M, Hu L, Bai P, Guo T, Liu N, Feng F, et al. LncRNA PCNAP1 promotes hepatoma cell proliferation through targeting miR-340-5p and is associated with patient survival. J Oncol. 2021;2021:6627173.","journal-title":"J Oncol"},{"issue":"6","key":"3849_CR62","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1159\/000495056","volume":"50","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Xu J, Zhang S, An J, Zhang J, Huang J, et al. HOXA-AS2 promotes proliferation and induces Epithelial-Mesenchymal transition via the miR-520c-3p\/GPC3 Axis in hepatocellular carcinoma. Cell Physiol Biochem. 2018;50(6):2124\u201338.","journal-title":"Cell Physiol Biochem"},{"issue":"1\u20132","key":"3849_CR63","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000452545","volume":"40","author":"F Wang","year":"2016","unstructured":"Wang F, Yang H, Deng Z, Su Y, Fang Q, Yin Z. HOX antisense LincRNA HOXA-AS2 promotes tumorigenesis of hepatocellular carcinoma. Cell Physiol Biochem. 2016;40(1\u20132):287\u201396.","journal-title":"Cell Physiol Biochem"},{"issue":"24","key":"3849_CR64","doi-asserted-by":"publisher","first-page":"e2306810","DOI":"10.1002\/advs.202306810","volume":"11","author":"Y Qin","year":"2024","unstructured":"Qin Y, Ren J, Yu H, He X, Cheng S, Chen W, et al. HOXA-AS2 epigenetically inhibits HBV transcription by recruiting the MTA1-HDAC1\/2 deacetylase complex to CccDNA minichromosome. Adv Sci (Weinh). 2024;11(24):e2306810.","journal-title":"Adv Sci (Weinh)"},{"key":"3849_CR65","doi-asserted-by":"crossref","unstructured":"Hsu CY, Jamal A, Kamal MA, Ahmad F, Bokov DO, Mustafa YF et al. Pathological roles of LncRNA HOTAIR in liver cancer: an updated review. Gene. 2024:149180.","DOI":"10.1016\/j.gene.2024.149180"},{"issue":"11","key":"3849_CR66","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1158\/0008-5472.CAN-14-2928","volume":"75","author":"H Zhang","year":"2015","unstructured":"Zhang H, Diab A, Fan H, Mani SK, Hullinger R, Merle P, et al. PLK1 and HOTAIR accelerate proteasomal degradation of SUZ12 and ZNF198 during hepatitis B Virus-Induced liver carcinogenesis. Cancer Res. 2015;75(11):2363\u201374.","journal-title":"Cancer Res"},{"issue":"22","key":"3849_CR67","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1042\/CS20200970","volume":"134","author":"F Ren","year":"2020","unstructured":"Ren F, Ren JH, Song CL, Tan M, Yu HB, Zhou YJ, et al. LncRNA HOTAIR modulates hepatitis B virus transcription and replication by enhancing SP1 transcription factor. Clin Sci (Lond). 2020;134(22):3007\u201322.","journal-title":"Clin Sci (Lond)"},{"key":"3849_CR68","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ebiom.2018.08.055","volume":"36","author":"D Cheng","year":"2018","unstructured":"Cheng D, Deng J, Zhang B, He X, Meng Z, Li G, et al. LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation. EBioMedicine. 2018;36:159\u201370.","journal-title":"EBioMedicine"},{"issue":"2","key":"3849_CR69","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5114\/ceh.2022.116820","volume":"8","author":"A El-Shendidi","year":"2022","unstructured":"El-Shendidi A, Ghazala R, Hassouna E. Circulating HOTAIR potentially predicts hepatocellular carcinoma in cirrhotic liver and prefigures the tumor stage. Clin Exp Hepatol. 2022;8(2):139\u201346.","journal-title":"Clin Exp Hepatol"},{"key":"3849_CR70","doi-asserted-by":"publisher","first-page":"114456","DOI":"10.1016\/j.jep.2021.114456","volume":"283","author":"J Wu","year":"2022","unstructured":"Wu J, Tang X, Shi Y, Ma C, Zhang H, Zhang J, et al. Crosstalk of LncRNA HOTAIR and SP1-mediated repression of PDK1 contributes to beta-Elemene-inhibited proliferation of hepatocellular carcinoma cells. J Ethnopharmacol. 2022;283:114456.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"3849_CR71","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1002\/jcb.26823","volume":"120","author":"B He","year":"2019","unstructured":"He B, Peng F, Li W, Jiang Y. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K\/Akt signaling. J Cell Biochem. 2019;120(3):2908\u201318.","journal-title":"J Cell Biochem"},{"issue":"11","key":"3849_CR72","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41419-024-07209-0","volume":"15","author":"X Bai","year":"2024","unstructured":"Bai X, Li J, Guo X, Huang Y, Xu X, Tan A, et al. LncRNA MALAT1 promotes Erastin-induced ferroptosis in the HBV-infected diffuse large B-cell lymphoma. Cell Death Dis. 2024;15(11):819.","journal-title":"Cell Death Dis"},{"issue":"8","key":"3849_CR73","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3349\/ymj.2019.60.8.727","volume":"60","author":"ZB Zhao","year":"2019","unstructured":"Zhao ZB, Chen F, Bai XF. Long noncoding RNA MALAT1 regulates hepatocellular carcinoma growth under hypoxia via sponging MicroRNA-200a. Yonsei Med J. 2019;60(8):727\u201334.","journal-title":"Yonsei Med J"},{"issue":"5","key":"3849_CR74","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1158\/1535-7163.MCT-19-0203","volume":"19","author":"L Fan","year":"2020","unstructured":"Fan L, Huang X, Chen J, Zhang K, Gu YH, Sun J, et al. Long noncoding RNA MALAT1 contributes to Sorafenib resistance by targeting miR-140-5p\/Aurora-A signaling in hepatocellular carcinoma. Mol Cancer Ther. 2020;19(5):1197\u2013209.","journal-title":"Mol Cancer Ther"},{"key":"3849_CR75","doi-asserted-by":"publisher","first-page":"101181","DOI":"10.1016\/j.drup.2024.101181","volume":"78","author":"CJ Shi","year":"2025","unstructured":"Shi CJ, Pang FX, Lei YH, Deng LQ, Pan FZ, Liang ZQ, et al. 5-methylcytosine methylation of MALAT1 promotes resistance to Sorafenib in hepatocellular carcinoma through ELAVL1\/SLC7A11-mediated ferroptosis. Drug Resist Updat. 2025;78:101181.","journal-title":"Drug Resist Updat"},{"key":"3849_CR76","doi-asserted-by":"crossref","unstructured":"Taiana E, Ronchetti D, Todoerti K, Nobili L, Tassone P, Amodio N et al. LncRNA NEAT1 in paraspeckles: A structural scaffold for cellular DNA damage response systems?? Noncoding RNA. 2020;6(3).","DOI":"10.3390\/ncrna6030026"},{"key":"3849_CR77","doi-asserted-by":"publisher","first-page":"102399","DOI":"10.1016\/j.ceb.2024.102399","volume":"90","author":"HB Ingram","year":"2024","unstructured":"Ingram HB, Fox AH. Unveiling the intricacies of paraspeckle formation and function. Curr Opin Cell Biol. 2024;90:102399.","journal-title":"Curr Opin Cell Biol"},{"issue":"1","key":"3849_CR78","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1091\/mbc.e13-09-0558","volume":"25","author":"T Hirose","year":"2014","unstructured":"Hirose T, Virnicchi G, Tanigawa A, Naganuma T, Li R, Kimura H, et al. NEAT1 long noncoding RNA regulates transcription via protein sequestration within subnuclear bodies. Mol Biol Cell. 2014;25(1):169\u201383.","journal-title":"Mol Biol Cell"},{"issue":"6","key":"3849_CR79","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1101\/gad.257048.114","volume":"29","author":"SB Hu","year":"2015","unstructured":"Hu SB, Xiang JF, Li X, Xu Y, Xue W, Huang M, et al. Protein arginine methyltransferase CARM1 attenuates the paraspeckle-mediated nuclear retention of mRNAs containing IRAlus. Genes Dev. 2015;29(6):630\u201345.","journal-title":"Genes Dev"},{"issue":"10","key":"3849_CR80","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/nsmb.3455","volume":"24","author":"L Jiang","year":"2017","unstructured":"Jiang L, Shao C, Wu QJ, Chen G, Zhou J, Yang B, et al. NEAT1 scaffolds RNA-binding proteins and the microprocessor to globally enhance pri-miRNA processing. Nat Struct Mol Biol. 2017;24(10):816\u201324.","journal-title":"Nat Struct Mol Biol"},{"issue":"5","key":"3849_CR81","doi-asserted-by":"publisher","first-page":"e22886","DOI":"10.1002\/jcla.22886","volume":"33","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, Wu W, Fu Y, Chen S, Chen T, Yang B, et al. Toll-like receptors, long non-coding RNA NEAT1, and RIG-I expression are associated with HBeAg-positive chronic hepatitis B patients in the active phase. J Clin Lab Anal. 2019;33(5):e22886.","journal-title":"J Clin Lab Anal"},{"key":"3849_CR82","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.biopha.2017.07.111","volume":"94","author":"Z Wang","year":"2017","unstructured":"Wang Z, Zou Q, Song M, Chen J. NEAT1 promotes cell proliferation and invasion in hepatocellular carcinoma by negative regulating miR-613 expression. Biomed Pharmacother. 2017;94:612\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"3849_CR83","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1002\/jcp.26371","volume":"233","author":"XN Zhang","year":"2018","unstructured":"Zhang XN, Zhou J, Lu XJ. The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3. J Cell Physiol. 2018;233(9):6733\u201341.","journal-title":"J Cell Physiol"},{"key":"3849_CR84","doi-asserted-by":"crossref","unstructured":"Fracchioni G, Vailati S, Grazioli M, Pirota V. Structural unfolding of G-Quadruplexes: from small molecules to antisense strategies. Molecules. 2024;29(15).","DOI":"10.3390\/molecules29153488"},{"issue":"1","key":"3849_CR85","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-021-01328-4","volume":"20","author":"N Kosiol","year":"2021","unstructured":"Kosiol N, Juranek S, Brossart P, Heine A, Paeschke K. G-quadruplexes: a promising target for cancer therapy. Mol Cancer. 2021;20(1):40.","journal-title":"Mol Cancer"},{"key":"3849_CR86","doi-asserted-by":"publisher","first-page":"111469","DOI":"10.1016\/j.cbi.2025.111469","volume":"412","author":"F Huang","year":"2025","unstructured":"Huang F, Liu Y, Huang J, He D, Wu Q, Zeng Y, et al. Small molecule as potent hepatocellular carcinoma progression inhibitor through stabilizing G-quadruplex DNA to activate replication stress responded DNA damage. Chem Biol Interact. 2025;412:111469.","journal-title":"Chem Biol Interact"},{"issue":"7","key":"3849_CR87","doi-asserted-by":"publisher","first-page":"e2320240121","DOI":"10.1073\/pnas.2320240121","volume":"121","author":"I Esain-Garcia","year":"2024","unstructured":"Esain-Garcia I, Kirchner A, Melidis L, Tavares RCA, Dhir S, Simeone A, et al. G-quadruplex DNA structure is a positive regulator of MYC transcription. Proc Natl Acad Sci U S A. 2024;121(7):e2320240121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3849_CR88","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1038\/s41467-022-33761-4","volume":"13","author":"KB Wang","year":"2022","unstructured":"Wang KB, Liu Y, Li J, Xiao C, Wang Y, Gu W, et al. Structural insight into the bulge-containing KRAS oncogene promoter G-quadruplex bound to Berberine and Coptisine. Nat Commun. 2022;13(1):6016.","journal-title":"Nat Commun"},{"issue":"33","key":"3849_CR89","doi-asserted-by":"publisher","first-page":"11179","DOI":"10.1021\/ja8031532","volume":"130","author":"Y Xu","year":"2008","unstructured":"Xu Y, Kaminaga K, Komiyama M. G-quadruplex formation by human telomeric repeats-containing RNA in Na\u2009+\u2009solution. J Am Chem Soc. 2008;130(33):11179\u201384.","journal-title":"J Am Chem Soc"},{"issue":"27","key":"3849_CR90","doi-asserted-by":"publisher","first-page":"9328","DOI":"10.1021\/ja100345z","volume":"132","author":"GW Collie","year":"2010","unstructured":"Collie GW, Parkinson GN, Neidle S, Rosu F, De Pauw E, Gabelica V. Electrospray mass spectrometry of telomeric RNA (TERRA) reveals the formation of stable multimeric G-quadruplex structures. J Am Chem Soc. 2010;132(27):9328\u201334.","journal-title":"J Am Chem Soc"},{"issue":"13","key":"3849_CR91","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1021\/bi301606u","volume":"52","author":"H Martadinata","year":"2013","unstructured":"Martadinata H, Phan AT. Structure of human telomeric RNA (TERRA): stacking of two G-quadruplex blocks in K(+) solution. Biochemistry. 2013;52(13):2176\u201383.","journal-title":"Biochemistry"},{"issue":"33","key":"3849_CR92","doi-asserted-by":"publisher","first-page":"14579","DOI":"10.1073\/pnas.1001177107","volume":"107","author":"Y Xu","year":"2010","unstructured":"Xu Y, Suzuki Y, Ito K, Komiyama M. Telomeric repeat-containing RNA structure in living cells. Proc Natl Acad Sci U S A. 2010;107(33):14579\u201384.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3849_CR93","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.cell.2017.06.017","volume":"170","author":"HP Chu","year":"2017","unstructured":"Chu HP, Cifuentes-Rojas C, Kesner B, Aeby E, Lee HG, Wei C, et al. TERRA RNA antagonizes ATRX and protects telomeres. Cell. 2017;170(1):86\u2013e10116.","journal-title":"Cell"},{"issue":"21","key":"3849_CR94","doi-asserted-by":"publisher","first-page":"12217","DOI":"10.1093\/nar\/gkac1114","volume":"50","author":"RX Tsai","year":"2022","unstructured":"Tsai RX, Fang KC, Yang PC, Hsieh YH, Chiang IT, Chen Y, et al. TERRA regulates DNA G-quadruplex formation and ATRX recruitment to chromatin. Nucleic Acids Res. 2022;50(21):12217\u201334.","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"3849_CR95","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1093\/bioinformatics\/btx498","volume":"33","author":"JM Garant","year":"2017","unstructured":"Garant JM, Perreault JP, Scott MS. Motif independent identification of potential RNA G-quadruplexes by G4RNA screener. Bioinformatics. 2017;33(22):3532\u20137.","journal-title":"Bioinformatics"},{"issue":"2","key":"3849_CR96","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1093\/nar\/gkt904","volume":"42","author":"JD Beaudoin","year":"2014","unstructured":"Beaudoin JD, Jodoin R, Perreault JP. New scoring system to identify RNA G-quadruplex folding. Nucleic Acids Res. 2014;42(2):1209\u201323.","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"3849_CR97","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1093\/nar\/gkw006","volume":"44","author":"A Bedrat","year":"2016","unstructured":"Bedrat A, Lacroix L, Mergny JL. Re-evaluation of G-quadruplex propensity with G4Hunter. Nucleic Acids Res. 2016;44(4):1746\u201359.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3849_CR98","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/nar\/gkab1208","volume":"50","author":"X Mou","year":"2022","unstructured":"Mou X, Liew SW, Kwok CK. Identification and targeting of G-quadruplex structures in MALAT1 long non-coding RNA. Nucleic Acids Res. 2022;50(1):397\u2013410.","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"3849_CR99","doi-asserted-by":"publisher","first-page":"9415","DOI":"10.1093\/nar\/gkad639","volume":"51","author":"A Ghosh","year":"2023","unstructured":"Ghosh A, Pandey SP, Joshi DC, Rana P, Ansari AH, Sundar JS, et al. Identification of G-quadruplex structures in MALAT1 LncRNA that interact with nucleolin and nucleophosmin. Nucleic Acids Res. 2023;51(17):9415\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"3849_CR100","first-page":"7421","volume":"48","author":"EAJ Simko","year":"2020","unstructured":"Simko EAJ, Liu H, Zhang T, Velasquez A, Teli S, Haeusler AR, et al. G-quadruplexes offer a conserved structural motif for NONO recruitment to NEAT1 architectural LncRNA. Nucleic Acids Res. 2020;48(13):7421\u201338.","journal-title":"Nucleic Acids Res"},{"key":"3849_CR101","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.biochi.2021.07.008","volume":"190","author":"U Bhatt","year":"2021","unstructured":"Bhatt U, Kretzmann AL, Guedin A, Ou A, Kobelke S, Bond CS, et al. The role of G-Quadruplex DNA in paraspeckle formation in cancer. Biochimie. 2021;190:124\u201331.","journal-title":"Biochimie"},{"issue":"9","key":"3849_CR102","doi-asserted-by":"publisher","first-page":"105151","DOI":"10.1016\/j.jbc.2023.105151","volume":"299","author":"J Wang","year":"2023","unstructured":"Wang J, Huang H, Zhao K, Teng Y, Zhao L, Xu Z, et al. G-quadruplex in hepatitis B virus pregenomic RNA promotes its translation. J Biol Chem. 2023;299(9):105151.","journal-title":"J Biol Chem"},{"issue":"5","key":"3849_CR103","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1093\/nar\/gkad1200","volume":"52","author":"G Giraud","year":"2024","unstructured":"Giraud G, Roda M, Huchon P, Michelet M, Maadadi S, Jutzi D, et al. G-quadruplexes control hepatitis B virus replication by promoting CccDNA transcription and phase separation in hepatocytes. Nucleic Acids Res. 2024;52(5):2290\u2013305.","journal-title":"Nucleic Acids Res"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03849-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03849-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03849-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T13:03:07Z","timestamp":1750510987000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03849-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3849"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03849-0","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"224"}}